David M. Polen
Polen Capital Management
Polen Capital Management ROIVANT SCIENCES LTD stake
total: 588
Polen Capital Management ROIV trades
- Total transactions:
- 3
- New positions:
- 2
- Sold out:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Polen Capital Management holds 8,659 ROIVANT SCIENCES LTD (ROIV) shares with a market value of roughly $306.44K accounting for 0.00% of the overall portfolio. To date, the estimated cost basis is nearly $35.39 for "buy" trades. Polen Capital Management first purchased ROIV in 2025 Q4, initially acquiring 9,662 shares. Polen Capital Management later completely sold out the position and invested in ROIVANT SCIENCES LTD again in 2026 Q2. Since the initial investment in ROIVANT SCIENCES LTD (ROIV), Polen Capital Management has made 2 more transactions.
When did Polen Capital Management buy ROIVANT SCIENCES LTD (ROIV)?
Polen Capital Management first invested in ROIVANT SCIENCES LTD (ROIV) in 2025 Q4 at the reported quarter-end price of $21.70 per share.
What's the cost basis of Polen Capital Management's ROIV stake?
The estimated cost basis for ROIVANT SCIENCES LTD (ROIV) stake is around $35.39 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $35.39
Polen Capital Management's historical trades in ROIVANT SCIENCES LTD
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
8,659
|
$35.39
|
$306,442
|
new
|
+0%
|
|
2026 Q1
|
0.00%
|
0
|
$21.70
|
|
-100% (-9,662)
|
-0%
|
|
2025 Q4
|
0.00%
|
9,662
|
$21.70
|
$209,665
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.